Close Menu

Michael Arrington has a post at the TechCrunch blog about his own experience sending in his DNA to 23andMe. Before you let out a "been there, done that" yawn, GTO has this to say -- Arrington raises a great issue that we haven't seen in anyone else's posts so far. What if, he asks, he just sends in someone else's DNA under his own name? Sure, a service company like 23andMe could easily distinguish male DNA from female.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.